Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous coronary intervention

Published:2006-01 Issue:1 Volume:29 Page:36-41
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Lipinski Michael J.,Martin Robert E.,Cowley Michael J.,Goudreau Evelyne,Malloy Walter N.,Johnson Robert E.,Vetrovec George W.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference22 articles.

1. Coronary artery disease as the cause of incident heart failure in the population;Fox;Eur Heart J,2001

2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group;N Engl J Med,1998

3. The Scandinavian Simvastatin Survival Study (4S);Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease;Lancet,1994

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators;Sacks;N Engl J Med,1996

5. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease;Kjekshus;J Card Fail,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients;Advances in Interventional Cardiology;2015

2. Understanding the role of B cells in atherosclerosis: potential clinical implications;Expert Review of Clinical Immunology;2013-12-02

3. Evidence-based management of patients undergoing PCI: Stent controversies;Catheterization and Cardiovascular Interventions;2010-03-01

4. Leukocytosis as a predictor for non-infective mortality and morbidity;QJM;2010-01-07

5. Recognizing and reducing the cardiac risk of renal failure;Catheterization and Cardiovascular Interventions;2008-08-26